Report Code : CVMI2603252601442 | Published Date : March 30, 2025
1 | Clinical Risk Grouping Solution Market Overview
The global clinical risk grouping solution market is experiencing strong growth as healthcare systems increasingly adopt advanced tools for patient stratification, cost prediction, and population health management. These solutions categorize patients based on clinical conditions, utilization patterns, and cost data, allowing payers and providers to develop targeted interventions and allocate resources more efficiently.
Driven by the rising need for value-based care, increasing healthcare costs, and the integration of AI-driven analytics, the market is expanding across both developed and emerging economies. The adoption is further supported by rising investments in healthcare IT infrastructure and the growing demand for predictive modeling.
2 | Market Size and Forecast
Year |
Market Value (USD Billion) |
Notes |
2019 |
1.4 |
Historical benchmark |
2024 |
2.3 |
Five-year CAGR 10.4% |
2031 |
4.8 |
Seven-year CAGR 10.9% |
3 | Key Market Drivers
- Shift Toward Value-Based Care Models.
- Rising Need for Predictive Analytics in Healthcare.
- Integration of AI and Machine Learning Algorithms.
- Growing Focus on Population Health Management.
- Government Incentives for Health IT Adoption.
4 | Market Challenges
- High Implementation Costs for Smaller Providers.
- Complex Integration with Legacy Systems.
- Data Privacy and Security Concerns.
- Limited Skilled Workforce for Data Interpretation.
5 | Competitive Landscape
Company |
Estimated Market Share |
Key Solutions |
Optum, Inc. |
20% |
Optum Risk Adjustment Solutions |
3M Health Information Systems |
18% |
Clinical Risk Group (CRG) system |
Cerner Corporation |
15% |
Population health and risk stratification tools |
Conifer Health Solutions |
10% |
Value-based care analytics |
Others |
37% |
Regional and niche providers |
6 | Market Segmentation
By Component:
- Software
- Services
By Deployment:
- On-Premise
- Cloud-Based
By Application:
- Population Health Management
- Risk Adjustment and Prediction
- Resource Allocation
By End User:
- Hospitals & Health Systems
- Payers
- Government Agencies
By Region:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
7 | Strategic Outlook
The market is set to benefit from AI-driven predictive models, cloud-based deployment, and the global move toward outcome-based reimbursement systems.
Reasons To Buy
• Benchmark key CRG tools and platform vendors by performance and adoption
• Track reimbursement-driven demand for risk stratification analytics
• Identify innovation opportunities in predictive modeling and SDOH integration
• Understand regulatory and policy trends impacting CRG tool deployment
Scope
• Market forecasts from 2019 to 2031 segmented by Component, deployment, Application, and region
• CRG technology roadmap with vendor capabilities and recent innovations
• Risk modeling trends for chronic care, value-based contracts, and population health
• Competitive benchmarking of CRG vendors and market shares
Key Players
- 3M Health Information Systems
- Optum
- Change Healthcare
- Conduent
- IBM Watson Health
- McKesson
- Cerner
- Medisolv
- 1. Global Clinical Risk Grouping Solution Market Research Report
- 1.1 Study Objectives
- 1.2 Global Clinical Risk Grouping Solution Market - Overview
- 1.3 Reason to Read This Report
- 1.4 Methodology and Forecast Analysis
- 2.1 Global Clinical Risk Grouping Solution Market Research Report – Detailed Scope and Definitions
- 2.1.1 By Product Type
- 2.1.2 By Application
- 2.1.3 By End-User
- 2.1.4 By Distribution Channel
- 2.1.5 By Region
- 3.1. Drivers - Macro-Economic Based, Supply Side, and Demand Side Drivers
- 3.2. Restraints – By Product Type, By Application, By End-User, By Distribution Channel, By Country
- 3.3. Opportunities – By Product Type, By Application, By End-User, By Distribution Channel, By Country
- 3.4. Trends – By Product Type, By Application, By End-User, By Distribution Channel, By Country
- 3.5. PEST Analysis
- 3.6. Porters Five Rule Analysis
- 3.7. Company’s Share Analysis (CSA) by Region or By Country
- 3.8. Global Clinical Risk Grouping Solution Market Research Report – DROTs Impact Analysis
- 4.1. Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 4.2. Annual Market Trend Assessment – Year-on-Year (YoY) Growth Analysis (%)
- 4.3. Incremental Market Value/Volume Opportunity between 2019 - 2023 and 2024 - 2031
- 4.4. Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.1 Standalone Software
- 5.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 5.2 Integrated Solutions
- 5.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 5.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 5.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 5.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.1 Population Health Management
- 6.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.2 Financial Risk Assessment
- 6.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 6.3 Clinical Decision Support
- 6.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 6.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 6.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 6.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.1 Hospitals
- 7.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.2 Insurance Companies
- 7.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 7.3 Research Institutions
- 7.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 7.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 7.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 7.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.1 Direct Sales
- 8.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.2 Online Retail
- 8.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 8.3 IT Vendors
- 8.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 8.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 8.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 8.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.1 North America
- 9.1.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.1.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.1.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.1.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.2 Europe
- 9.2.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.2.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.2.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.2.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.3 Asia-Pacific
- 9.3.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.3.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.3.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.3.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.4 Latin America
- 9.4.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.4.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.4.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.4.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.5 Middle East & Africa
- 9.5.1 Market Performance Review & Future Outlook: Assessing 2019 - 2023 and Predicting 2024 - 2031 Trends (USD Millions)
- 9.5.2 Annual Market Trend Assessment – Yearly Growth Observation (Y-O-Y)(%)
- 9.5.3 Incremental Market Value/Volume Opportunity between 2019 - 2023 and From 2024 to 2031
- 9.5.4 Market Shares Analysis in Years - 2019, 2023, 2024 and 2031
- 9.6 Global Clinical Risk Grouping Solution Market - Opportunity Analysis Index, By Product Type, By Application, By End-User, By Distribution Channel, and Region, 2024 - 2031
- 10.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 10.1.1 Standalone Software
- 10.1.2 Integrated Solutions
- 10.2.1 Population Health Management
- 10.2.2 Financial Risk Assessment
- 10.2.3 Clinical Decision Support
- 10.3.1 Hospitals
- 10.3.2 Insurance Companies
- 10.3.3 Research Institutions
- 10.4.1 Direct Sales
- 10.4.2 Online Retail
- 10.4.3 IT Vendors
- 10.5.1 United States
- 10.5.2 Canada
10.7 Regional Trends Analysis
10.8 North America Global Clinical Risk Grouping Solution Market Research Report - Company Profiles- 10.8.1 Company 1 (United States)
- 10.8.2 Company 2 (Canada)
- 10.8.3 Company 3 (Canada)
- 11.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 11.1.1 Standalone Software
- 11.1.2 Integrated Solutions
- 11.2.1 Population Health Management
- 11.2.2 Financial Risk Assessment
- 11.2.3 Clinical Decision Support
- 11.3.1 Hospitals
- 11.3.2 Insurance Companies
- 11.3.3 Research Institutions
- 11.4.1 Direct Sales
- 11.4.2 Online Retail
- 11.4.3 IT Vendors
- 11.5.1 Germany
- 11.5.2 United Kingdom
- 11.5.3 France
- 11.5.4 Spain
- 11.5.5 Italy
- 11.5.6 Russia
- 11.5.7 Netherlands
- 11.5.8 Poland
- 11.5.9 Rest of Europe
11.7 Regional Trends Analysis
11.8 Europe Global Clinical Risk Grouping Solution Market Research Report - Company Profiles- 11.8.1 Company 1 (Germany)
- 11.8.2 Company 2 (United Kingdom)
- 11.8.3 Company 3 (United Kingdom)
- 12.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 12.1.1 Standalone Software
- 12.1.2 Integrated Solutions
- 12.2.1 Population Health Management
- 12.2.2 Financial Risk Assessment
- 12.2.3 Clinical Decision Support
- 12.3.1 Hospitals
- 12.3.2 Insurance Companies
- 12.3.3 Research Institutions
- 12.4.1 Direct Sales
- 12.4.2 Online Retail
- 12.4.3 IT Vendors
- 12.5.1 China
- 12.5.2 Japan
- 12.5.3 India
- 12.5.4 South Korea
- 12.5.5 Australia & NZ
- 12.5.6 ASEAN
- 12.5.7 Rest of Asia-Pacific
12.7 Regional Trends Analysis
12.8 Asia-Pacific Global Clinical Risk Grouping Solution Market Research Report - Company Profiles- 12.8.1 Company 1 (China)
- 12.8.2 Company 2 (Japan)
- 12.8.3 Company 3 (Japan)
- 13.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 13.1.1 Standalone Software
- 13.1.2 Integrated Solutions
- 13.2.1 Population Health Management
- 13.2.2 Financial Risk Assessment
- 13.2.3 Clinical Decision Support
- 13.3.1 Hospitals
- 13.3.2 Insurance Companies
- 13.3.3 Research Institutions
- 13.4.1 Direct Sales
- 13.4.2 Online Retail
- 13.4.3 IT Vendors
- 13.5.1 Brazil
- 13.5.2 Mexico
- 13.5.3 Argentina
- 13.5.4 Peru
- 13.5.5 Colombia
- 13.5.6 Rest of Latin America
13.7 Regional Trends Analysis
13.8 Latin America Global Clinical Risk Grouping Solution Market Research Report - Company Profiles- 13.8.1 Company 1 (Brazil)
- 13.8.2 Company 2 (Mexico)
- 13.8.3 Company 3 (Mexico)
- 14.1 By Product Type Analysis 2019 - 2023 and Forecast, 2024 - 2031 by Market Assessment (USD Mn), Yearly Growth Rate (%), and Market Presence (%)
- 14.1.1 Standalone Software
- 14.1.2 Integrated Solutions
- 14.2.1 Population Health Management
- 14.2.2 Financial Risk Assessment
- 14.2.3 Clinical Decision Support
- 14.3.1 Hospitals
- 14.3.2 Insurance Companies
- 14.3.3 Research Institutions
- 14.4.1 Direct Sales
- 14.4.2 Online Retail
- 14.4.3 IT Vendors
- 14.5.1 Saudi Arabia
- 14.5.2 UAE
- 14.5.3 South Africa
- 14.5.4 Egypt
- 14.5.5 Israel
- 14.5.6 Rest of Middle East and Africa
14.7 Regional Trends Analysis
14.8 Middle East & Africa Global Clinical Risk Grouping Solution Market Research Report - Company Profiles- 14.8.1 Company 1 (Saudi Arabia)
- 14.8.2 Company 2 (UAE)
- 14.8.3 Company 3 (UAE)
- 15.1 Strategic Dashboard of Top Market Players
15.2 Company Profiles (Introduction, Financial Assessments, Portfolio of Offerings, Milestones and Achievements, Strategic Initiative, and SWOT Analysis)- 15.2.1 3M Health Information Systems
- 15.2.2 Optum
- 15.2.3 Change Healthcare
- 15.2.4 Conduent
- 15.2.5 IBM Watson Health
- 15.2.6 McKesson
- 15.2.7 Cerner
- 15.2.8 Medisolv
17. Principal Presumptions and Acronyms